Related Experiment Video

Updated: Aug 19, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
05:57

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

Hypertension, stroke, and endothelium

Francesco Cosentino1, Massimo Volpe

  • 1Division of Cardiology, University La Sapienza, Ospedale Sant'Andrea, Via di Grottarossa, 1035, 00189 Rome, Italy.

Current Hypertension Reports
|February 3, 2005
PubMed

Insights

Endothelial dysfunction, a condition affecting blood vessel lining, is increasingly implicated in cardiovascular diseases. This review explores its role in the development of ischemic stroke, even with controlled blood pressure.

Area of Science:

  • Cardiovascular Science
  • Neurology
  • Vascular Biology

Background:

  • Endothelial dysfunction is a key feature in cardiovascular diseases, arising from various injuries.
  • It may act as a marker and a driver of disease progression and poor outcomes.
  • Stroke is a prime example of a cerebrovascular event potentially linked to endothelial dysfunction.

Purpose of the Study:

  • To review current evidence on the role of endothelial dysfunction in the pathogenesis of ischemic stroke.
  • To explore factors beyond blood pressure contributing to stroke risk.
  • To understand the increasing secular trends of stroke in controlled populations.

Main Methods:

  • Review of existing epidemiologic evidence.
  • Analysis of current scientific literature on endothelial dysfunction and stroke.
  • Examination of the relationship between blood pressure control and stroke incidence.

Main Results:

  • Endothelial dysfunction is a significant factor in cardiovascular pathology.
  • Evidence suggests a role for endothelial dysfunction in the pathogenesis of ischemic stroke.
  • Factors other than elevated blood pressure are important in stroke development.

Conclusions:

  • Endothelial dysfunction plays a critical role in the development of ischemic stroke.
  • Further research into endothelial dysfunction mechanisms is warranted for stroke prevention.
  • Understanding endothelial dysfunction may explain increasing stroke trends despite blood pressure control.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...